MAPK p38 activity assay was performed as described before (Huang et al., 1999). NCM460 cells were seeded at 20.000 cells/cm2 in 6-well plates and grown for 3 days before treatment. For kinetic measurements, cells were treated with the CM for different periods. For evaluation of STW5 and STW5-II effects, cells were preincubated with the combination preparations for 4 h before adding the CM. Lysed cells were incubated overnight with immobilized anti-pp38 antibody beads. Kinase assays were performed by incubating the immunoprecipitates with ATF-2 fusion protein and ATP for 30 min at 30°C. The pATF-2 content was determined by western blot.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.